Intuitive Surgical, Inc.
NASDAQ:ISRGMedical - Devices
+$3.65 today
- Market cap
- $145.92B
- Beta
- 1.45
- P/E (TTM)
- 48.3
- EPS (TTM)
- $8.39
Volume 2.20M
Average 2.21M
ISRG Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Intuitive Surgical, Inc.NASDAQ: ISRG
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $113.1M (cash outflow) rose 7.3% year over year, ahead of the -28.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +0.5% a year.
Context
- Capital expenditures amounted to 5.4% of revenue in FY2025, down 7.9 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +7.3% holds above the trailing-twelve-month pace of -28.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (539.8M) USD
- Year-over-year change
- +51.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (539.8M) | +51.4% |
| FY2024 | 2024-12-31 | (1.11B) | -4.4% |
| FY2023 | 2023-12-31 | (1.06B) | -99.9% |
| FY2022 | 2022-12-31 | (532.4M) | -50.6% |
| FY2021 | 2021-12-31 | (353.5M) | — |
Capital Expenditures vs competitors
How ISRG compares with its peers on the latest reported figures
- ISRG's LTM Sep 2026 capital expenditures of $491.5M is the 2nd largest of the 5 companies compared; the peer median is $225.96M.
- Its year-over-year change of -28.7% is the lowest of 5, against a peer median of +20.6%.
- Capital expenditures amounts to 4.2% of revenue for ISRG, versus a peer median of 5.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $823M | +10.9% | +9.0% | 3.2% | |
| LTM Sep 2026 | $491.5M | -28.7% | +0.5% | 4.2% | |
| FY2025 | $433M | +13.6% | +6.5% | 7.0% | |
| LTM Mar 2026 | $18.92M | +27.6% | -3.1% | 1.4% | |
| LTM Mar 2026 | $155K | +545.8% | -10.6% | 147.6% | |
| Peer median (excluding ISRG) | $225.96M | +20.6% | +1.7% | 5.1% | |
Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.73B | 1.34B | 1.82B | 2.34B | 2.88B |
| Depreciation & Amortization | 310.2M | 365.8M | 454.8M | 462M | 677.1M |
| Deferred Income Tax | (62.6M) | (185.3M) | (280.8M) | (135.3M) | 19.1M |
| Stock-Based Compensation | 449.2M | 513.2M | 598.2M | 676.8M | 788.2M |
| Change in Working Capital | (368.1M) | (619.1M) | (777.6M) | (919.3M) | (1.27B) |
| Accounts Receivables | (142.3M) | (159.3M) | (186.3M) | (95.9M) | (301.7M) |
| Inventory | (256M) | (546.6M) | (712.5M) | (830M) | (1.06B) |
| Accounts Payables | 36M | 21.3M | 41.7M | (400K) | 57.9M |
| Other Working Capital | (5.8M) | 65.5M | 79.5M | 7M | 34.9M |
| Other Non-Cash Items | 32.6M | 71.8M | 1.9M | (6.7M) | (58.2M) |
| Operating Cash Flow | 2.09B | 1.49B | 1.81B | 2.42B | 3.03B |
| Capital Expenditures | (353.5M) | (532.4M) | (1.06B) | (1.11B) | (539.8M) |
| Acquisitions (Net) | (8.7M) | (12.8M) | (8.9M) | (1M) | (13.9M) |
| Purchases of Investments | (6.45B) | (1.4B) | (2.21B) | (5.14B) | (1.22B) |
| Sales of Investments | 4.35B | 3.32B | 2.92B | 2.98B | 2.44B |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (2.46B) | 1.37B | (360.1M) | (3.27B) | 665.8M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 276.5M | 0 | 296.3M | 429.4M | 350.3M |
| Common Stock Repurchased | 0 | (2.61B) | (416.3M) | 0 | (2.3B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (233.5M) | (198.7M) | (167.6M) | (278.5M) | (419.1M) |
| Financing Cash Flow | 43M | (2.57B) | (287.6M) | 150.9M | (2.36B) |
| Effect of Forex Changes | (3.4M) | 5.4M | 3.3M | (800K) | 12.8M |
| Net Change in Cash | (332.5M) | 294.7M | 1.17B | (707.7M) | 1.35B |
| Free Cash Flow | 1.74B | 958.4M | 749.6M | 1.3B | 2.49B |
Intuitive Surgical, Inc.
NASDAQ:ISRG
Intrinsic Alpha fair value
Locked
Current Price
$420.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.